Phase II clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003961:Dianhydrogalactitol / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D013402:Sugar Alcohols / Q000627:therapeutic use*
D013402:Sugar Alcohols; D003961:Dianhydrogalactitol